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I held her hand; her wasted arm revealing the 
anatomy of every bone and muscle. Her eyes 
were closed, weighed down by the burden of 
disease. She lay upon the bed in my consulting 
room and there, with no fanfare, she breathed 
her last breath, passing effortlessly from life into death. Ironically, 
it was 1 December 2000, World AIDS Day. The patient was a 
nursing sister and her decline in the face of no antiretroviral 
therapy (ART) had been harrowing. At times like these, the 
futilty of working in an HIV clinic was overwhelming, and 
I fought tears as I turned with a heavy heart to deal with the 
devastated family as best I could. 
I had arrived in KwaZulu-Natal from my native Britain in 1997 
to work for two years. I soon realised that the numbers of HIV-
infected people were growing inexorably, but that no-one really 
knew what to do with those individuals who had summoned 
the courage to take an HIV test and had a positive result. Triple-
drug ART was new, even in Europe, and virtually unheard of 
in the hospitals in which I was working. Knowledge about the 
natural course and management of HIV was limited, even among 
healthcare professionals. 
On the wards if a patient had ‘the label’ (coded in various 
subtle ways in the doctors’ notes), then doctors and nurses would 
often not fully address whatever the presenting problem was – 
even if it was unrelated to HIV. There would be hushed tones on 
the ward round, a shrugging of shoulders and a general feeling 
that there was nothing much more that could be done. Little 
wonder that time and again patients would refuse to be tested, 
even in the face of all the stigmata of advanced HIV infection. 
Because, at that time, to test positive meant that your medical 
team might have looked no further for what was actually wrong 
with you. In effect, you would have been sent home to die. 
It seemed that we doctors hated the diagnosis almost as 
much as the patients did. It called us failures; it labelled us as 
incompetent, inept, ineffectual; it mocked our training and 
humbled us as we fought to cope with the burgeoning numbers 
inundating our services. We had no oral antifungal agents – 
just gentian violet. Amphotericin B was extremely difficult 
to obtain and cryptococcal meningitis, when the diagnosis 
was actually made, was almost universally fatal. There were 
virtually no HIV services, and patients were often literally 
neglected as they trod the terrifying path of opportunistic 
infections to their death. 
In 1999, I started working at a government hospital in Pieter-
maritz burg. There, an insightful and committed physician had 
started an HIV clinic (one of the first in KwaZulu-Natal) and I 
remember clearly how incredulous and excited I was about this! 
Someone was willing to see these patients; someone actually 
wanted to see these patients! Someone felt they had something 
to offer in the face of the HIV monster which had thus far 
defeated all the doctors I knew! I was captivated by the thought 
and it was not long before I joined the clinic. Although we had 
no antiretrovirals (ARVs), we provided something that these 
patients hadn’t hitherto experienced: a place where they were 
welcomed because of their HIV status. 
Elsewhere in society and in the healthcare system at that time, 
people living with HIV were rejected and ostracised. But in 
an HIV clinic, they were embraced. We got to know and care 
about our patients; we treated their opportunistic infections; we 
obtained disability grants for them; and we spent many hours 
counselling about death and dying, allowing people to explore 
and verbalise their fears. We encouraged mothers to make 
memory boxes for their children and we galvanised patients to 
put their affairs in order before they died.
We tried to read as much as we could about HIV manage-
ment; we gave isoniazid and cotrimoxazole prophyl axis and we 
obtained a supply of ketoconazole for oesophageal candidiasis. 
There were so many things we didn’t know. The internet was 
limited and we relied heavily on our manuals to teach ourselves 
HIV medicine. It became increasingly obvious that ARVs were 
going to be the only solution for our burdened country. How 
many heated discussions were had around this topic! Many 
people felt that such an expense could never be borne by a 
middle-income country with such a vast HIV epidemic. 
‘It seemed that we doctors hated 
the diagnosis almost as much 
as the patients did. It called 
us failures; it labelled us as 
incompetent, inept, ineffectual; 
it mocked our training and 
humbled us as we fought to cope 
with the burgeoning numbers 
inundating our services.’













In 2000, we started prescribing the cheapest ARV drugs in a desperate 
attempt to do something that could slow down the disease progression. 
And so Bongani, weak and wasted, with histoplasmosis of the palate, 
was our first patient to receive didanosine (which he paid for) and 
hydroxyurea (which we supplied). Amazingly, he blossomed on what is 
now considered substandard, toxic dual therapy, and we marvelled in 
wonder at his improved health! This was the first time we had ever seen 
the disease checked and reversed. 
Next, didanosine and stavudine became available for US$1 per day. 
This was affordable to a number of patients and it worked! It was 
relatively durable and we saw people rally. Very few people in South 
Africa at this time knew much about HIV treatment. We constantly 
felt like isolated and lonely pioneers, chasing the pipedream of triple 
therapy. Those were the days when the government dragged its 
collective feet in almost everything concerning the treatment of HIV 
and the Treatment Action Campaign had to force them into the courts.
Later, the advent of relatively cheap efavirenz meant that at last we 
could initiate patients on really effective ART. The caveat of course was 
that they had to pay R700 for one month’s supply. Those who could 
afford it sat side by side with those who couldn’t, which was a huge 
source of frustration for all of us. We continued to be astounded by 
the effect that these drugs had on our patients. After so many years of 
losing countless lives, at last we had a weapon with which to fight back, 
and it was a glorious feeling. We still lacked adequate monitoring (it 
was difficult to convince people to spend R750 testing their viral load 
privately) and we learnt hard lessons as we saw peripheral neuropathy, 
lactic acidosis and drug-related deaths.
Early in 2003 the air was thick with rumours that soon the 
government would introduce a national ART programme. When 
the moment actually arrived, it was a cause of great celebration. The 
package was comprehensive and at last we could monitor patients’ 
responses to therapy. Our KwaZulu-Natal Department of Health 
seemed really committed, with our Minister of Health, Dr Zweli 
Mkhize, even coming to work at the clinic on Monday mornings!
I still work with HIV – having been privileged to have witnessed 
the enormous mobilisation of resources and commitment that has 
brought us to where we stand today as a country. The HIV story of 
South Africa continues to evolve, but for me, the battle will never be 
as fierce again. 
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‘Although we had no antiretrovirals, 
we provided something that these 
patients hadn’t hitherto experienced: 
a place where they were welcomed 
because of their HIV status.’
‘After so many years of losing 
countless lives, at last we had 
a weapon with which to fight 
back ... ’
